The impact of first trimester fasting glucose level on adverse perinatal outcome

Lina Salman*, Nissim Arbib, Adi Borovich, Anat Shmueli, Rony Chen, Arnon Wiznitzer, Eran Hadar

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: To evaluate the impact of first trimester fasting glucose (FTFG) level on perinatal outcome. Study design: A retrospective cohort study of singleton deliveries. Maternal and neonatal outcome were compared between two groups - women with FTFG < 95 mg/dl and FTFG ≥ 95 mg/dl. Women with pre-gestational diabetes were excluded. Results: Five thousand and thirty women met inclusion criteria. Of whom, 4644 (92.3%) had FTFG < 95 mg/dl and 386 (7.7%) had FTFG ≥ 95 mg/dl. Women with FTFG ≥ 95 mg/dl had higher rates of gestational hypertension (2.33 vs. 0.7%) and gestational diabetes (9.07 vs. 2.86%), p < 0.05 for both. Moreover, they had higher rates of cesarean delivery and arrest of descent, p < 0.05. Composite diabetes outcome was significantly higher among women with FTFG ≥ 95 mg/dl (8 vs. 3%, p = 0.002). After adjusting for potential confounders, composite diabetes outcome (aOR = 1.942 95% CI 1.265-2.981, p = 0.002) and gestational hypertension (aOR = 2.827 95% CI 1.295-6.175, p = 0.009) remained significantly higher in the FTFG ≥ 95 mg/dl group. Conclusion: FTFG ≥ 95 mg/dl is an independent risk factor for adverse perinatal outcome including gestational hypertension and diabetes-related complications.

Original languageEnglish
Pages (from-to)451-455
Number of pages5
JournalJournal of Perinatology
Volume38
Issue number5
DOIs
StatePublished - 1 May 2018
Externally publishedYes

Fingerprint

Dive into the research topics of 'The impact of first trimester fasting glucose level on adverse perinatal outcome'. Together they form a unique fingerprint.

Cite this